Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

An AARS variant as the li… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids

Artikel i vetenskaplig tidskrift
Författare Christina Sundal
Susana Carmona
Maria Yhr
Odd Almström
Maria Ljungberg
John Hardy
Carola Oldfors Hedberg
Åsa Fred
José Bras
Anders Oldfors
Oluf Andersen
Rita Guerreiro
Publicerad i Acta Neuropathologica Communications
Volym 7
Sidor 188
Publiceringsår 2019
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för radiofysik
Institutionen för biomedicin, avdelningen för laboratoriemedicin
Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap
Sidor 188
Språk en
Länkar https://doi.org/10.1186/s40478-019-...
Ämnesord Swedish type hereditary diffuse Leukoencephalopathy with spheroids, HDLS, Alanyl tRNA synthetase, AARS
Ämneskategorier Klinisk medicin

Sammanfattning

Swedish type Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS-S) is a severe adult-onset leukoencephalopathy with the histopathological hallmark of neuraxonal degeneration with spheroids, described in a large family with a dominant inheritance pattern. The initial stage of the disease is dominated by frontal lobe symptoms that develop into a rapidly advancing encephalopathy with pyramidal, deep sensory, extrapyramidal and optic tract symptoms. Median survival is less than 10 years. Recently, pathogenic mutations in CSF1R were reported in a clinically and histologically similar leukoencephalopathy segregating in several families. Still, the cause of HDLS-S remained elusive since its initial description in 1984, with no CSF1R mutations identified in the family. Here we update the original findings associated with HDLS-S after asystematic and recent assessment of several family members. We also report the results from exome sequencing analysesindicating the p.Cys152Phe variant in the alanyl tRNA synthetase (AARS) gene as the probable cause of this disease. The variant affects an amino acid located in the aminoacylation domain of the protein and does not cause differences in splicing or expression in the brain. Brain pathology in one case after 10 years of disease duration showed the end stage of the disease to be characterized by widespread liquefaction of the white matter leaving only some macrophages and glial cells behind the centrifugally progressing front. These results point to AARS as a candidate gene for rapidly progressing adult onset CSF1R-negative leukoencephalopathies.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?